Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Journal: JCO precision oncology
Published: September 15, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
Journal: Surgical oncology
Published: July 18, 2022
Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
Journal: Journal of cancer survivorship : research and practice
Published: June 09, 2022
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Journal: Breast cancer research and treatment
Published: May 30, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Journal: Annals of surgical oncology
Published: October 11, 2021
A novel, adaptable, radiographically opaque, multi-plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow-up.
Journal: Gland surgery
Published: February 12, 2020
Breast Cancer Survivorship: Why, What and When?
Journal: Annals of surgical oncology
Published: April 18, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026